CAMP4 Therapeutics Corporation

Animal Exploitation (Testing): Yes Link: CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 in SYNGAP1-Related Disorders – Quiver Quantitative Short Description: CAMP4 Therapeutics is a clinical-stage biotechnology company that develops new medicines. As part of the necessary preclinical development for its drug candidates, the company uses animal testing for both proof-of-concept/efficacy and regulatory toxicology. Specifically, public reports confirm the use of mice and non-human primates (NHPs) in its drug programs.